| 口服纳米银对大鼠的生物有效性及其体内分布的研究 |
| |
| 引用本文： | 江媛媛,党菲,李敏,周东美,吴笛,施维林,朱雪峰,#.口服纳米银对大鼠的生物有效性及其体内分布的研究[J].生态毒理学报,2017,12(3):215-222. |
| |
| 作者姓名： | 江媛媛 党菲 李敏 周东美 吴笛 施维林 朱雪峰 # |
| |
| 作者单位： | 1.苏州科技大学环境科学与工程学院， 苏州 215009
2.中国科学院南京土壤研究所土壤环境与污染修复重点实验室， 南京 210008
3.南京医科大学公共卫生学院毒理系， 南京 210029
4.南京医科大学公共卫生学院江苏省医药兽药安全性评价与研究中心，南京 210029 |
| |
| 基金项目： | 国家自然科学基金项目(No. 41430752, 31570515)；江苏省自然科学基金项目 (BK20131041)；苏州市科技支撑计划项目(SS201421，SS201523)；江苏高校水处理技术与材料协同创新项目； 苏州市环保科技项目(2015-3) |
| |
| 摘 要： | 由于独特的抗菌特性，纳米银(AgNP)在诸多领域得到广泛应用，但是其生物有效性、动物组织分布及排出尚不清楚。将聚乙烯吡咯烷酮包被的AgNP溶液按照10 mg kg-1给雌性SD大鼠灌胃，采用ICP-MS检测SD大鼠组织、粪便及尿液中总银浓度。实验结果表明，AgNP通过小肠吸收后，可以通过血液循环快速分布在肝、肾、脾、肺、脑等靶器官。灌胃后1 h，大鼠各组织中总银浓度达到最大值(肝、肾、脾、肺、脑中银浓度分别为0.29 ± 0.13 mg kg-1、0.23 ± 0.04 mg kg-1、0.17 ± 0.05 mg kg-1、0.11 ± 0.01 mg kg-1、0.06 ±0.02 mg kg-1)，之后银浓度随时间降低直至和对照组无显著性差异。在灌胃途径下，AgNP对SD大鼠的有效性为8.5%，且73%的AgNP是通过粪便的途径排出体外。
|
| 关 键 词： | AgNP SD大鼠 累积 生物有效性 |
| 收稿时间： | 2016/9/2 0:00:00 |
| 修稿时间： | 2016/10/24 0:00:00 |
Bioavailability and Distribution of Nanosilver after Oral Administration in Rats |
| |
| Jiang Yuanyuan,Dang Fei,Li Min,Zhou Dongmei,Wu Di,Shi Weilin,Zhu Xuefeng,#.Bioavailability and Distribution of Nanosilver after Oral Administration in Rats[J].Asian Journal of Ecotoxicology,2017,12(3):215-222. |
| |
| Authors: | Jiang Yuanyuan Dang Fei Li Min Zhou Dongmei Wu Di Shi Weilin Zhu Xuefeng # |
| |
| Institution: | 1. School of Environmental Science and Engineering, Suzhou University of Science and Technology, Suzhou 215009, China
2. Key Laboratory of Soil Environment and Pollution Remediation, Institute of Soil Science, Chinese Academy of Sciences, Nanjing 210008, China
3. Department of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 210029, China
4. Safety Evaluation and Research Center of Jiangsu Province Medicine and Veterinary Medicine, School of Public Health, Nanjing Medical University, Nanjing 210029, China |
| |
| Abstract: | Due to the unique antimicrobial properties, nanosilver (AgNP) are being widely applied in many fields. However, its bioavailability, tissue distribution and excretion in rats are less known. Female Sprague - Dawley rats were treated by a single intragastic administration of 10 mg kg-1 polyvinylpyrrolidone-AgNPs, and rate tissues, feces and urine were collected periodically to analyze total Ag concentrations by ICP-MS. The results showed that after uptake by gastrointestine, AgNP was transported via the blood circulation and distributed to tissues such as liver, kidney, spleen, lung, and brain. At 1 h after AgNP exposure, total silver accumulation in those tissues peaked (i.e. 0.29 ± 0.13 mg kg-1, 0.23 ± 0.04 mg kg-1, 0.17 ± 0.05 mg kg-1, 0.11 ± 0.01 mg kg-1 and 0.06 ± 0.02 mg kg-1 for liver, kidney, spleen, lung and brain, respectively), and declined to background levels over time. Our calculation showed that the bioavailability of AgNP to Sprague - Dawley rats via intragastric administration was 8.5%. Especially, 73% of the dosed AgNP was excreted via feces. |
| |
| Keywords: | AgNP Sprague - Dawley rats accumulation bioavailability |
|
| 点击此处可从《生态毒理学报》浏览原始摘要信息 |
| 点击此处可从《生态毒理学报》下载免费的PDF全文 |
|
